Antiapoptotic therapies in the treatment of spinal cord injury

Diana M. Cittelly, J. Regino Perez-Polo

    Research output: Contribution to journalArticle

    Abstract

    Mechanical trauma to the spinal cord triggers events resulting in the death of neurons and glia over several weeks following the initial injury. It has been suggested that the prevention of delayed apoptosis after spinal cord injury (SCI) is likely to have a beneficial effect by reducing the extent of neuronal and oligodendroglial death, which would translate into better functional outcomes. Drugs acting at different levels in the apoptotic cascade (i.e., caspase inhibitors and antiapoptotic Bcl-xL) have been shown to decrease apoptotic cell death, but benefits in functional outcomes result only when inflammation is also decreased. Furthermore, long-term antiapoptotic therapy can result in nonapoptotic death with necrotic features, which will further increase inflammation and worsen outcome. Even though neuroprotective therapies are one of the targets for the promotion of functional recovery after SCI, targeting only post-SCI apoptosis is unlikely to be as successful as more integrated interventions that also target inflammation.

    Original languageEnglish (US)
    Pages (from-to)425-434
    Number of pages10
    JournalFuture Neurology
    Volume2
    Issue number4
    DOIs
    StatePublished - Jul 2007

    Fingerprint

    Spinal Cord Injuries
    Inflammation
    Apoptosis
    Caspase Inhibitors
    Therapeutics
    Neuroglia
    Cell Death
    Neurons
    Wounds and Injuries
    Pharmaceutical Preparations

    Keywords

    • Apoptosis
    • Bcl-2 family
    • Bcl-xL
    • Caspases
    • Functional recovery
    • Inflammation
    • Necrosis
    • Neuronal cell death

    ASJC Scopus subject areas

    • Neurology
    • Clinical Neurology

    Cite this

    Antiapoptotic therapies in the treatment of spinal cord injury. / Cittelly, Diana M.; Perez-Polo, J. Regino.

    In: Future Neurology, Vol. 2, No. 4, 07.2007, p. 425-434.

    Research output: Contribution to journalArticle

    Cittelly, Diana M. ; Perez-Polo, J. Regino. / Antiapoptotic therapies in the treatment of spinal cord injury. In: Future Neurology. 2007 ; Vol. 2, No. 4. pp. 425-434.
    @article{6b26f1d32fc745dbb56fcf6776b85a69,
    title = "Antiapoptotic therapies in the treatment of spinal cord injury",
    abstract = "Mechanical trauma to the spinal cord triggers events resulting in the death of neurons and glia over several weeks following the initial injury. It has been suggested that the prevention of delayed apoptosis after spinal cord injury (SCI) is likely to have a beneficial effect by reducing the extent of neuronal and oligodendroglial death, which would translate into better functional outcomes. Drugs acting at different levels in the apoptotic cascade (i.e., caspase inhibitors and antiapoptotic Bcl-xL) have been shown to decrease apoptotic cell death, but benefits in functional outcomes result only when inflammation is also decreased. Furthermore, long-term antiapoptotic therapy can result in nonapoptotic death with necrotic features, which will further increase inflammation and worsen outcome. Even though neuroprotective therapies are one of the targets for the promotion of functional recovery after SCI, targeting only post-SCI apoptosis is unlikely to be as successful as more integrated interventions that also target inflammation.",
    keywords = "Apoptosis, Bcl-2 family, Bcl-xL, Caspases, Functional recovery, Inflammation, Necrosis, Neuronal cell death",
    author = "Cittelly, {Diana M.} and Perez-Polo, {J. Regino}",
    year = "2007",
    month = "7",
    doi = "10.2217/14796708.2.4.425",
    language = "English (US)",
    volume = "2",
    pages = "425--434",
    journal = "Future Neurology",
    issn = "1479-6708",
    publisher = "Future Medicine Ltd.",
    number = "4",

    }

    TY - JOUR

    T1 - Antiapoptotic therapies in the treatment of spinal cord injury

    AU - Cittelly, Diana M.

    AU - Perez-Polo, J. Regino

    PY - 2007/7

    Y1 - 2007/7

    N2 - Mechanical trauma to the spinal cord triggers events resulting in the death of neurons and glia over several weeks following the initial injury. It has been suggested that the prevention of delayed apoptosis after spinal cord injury (SCI) is likely to have a beneficial effect by reducing the extent of neuronal and oligodendroglial death, which would translate into better functional outcomes. Drugs acting at different levels in the apoptotic cascade (i.e., caspase inhibitors and antiapoptotic Bcl-xL) have been shown to decrease apoptotic cell death, but benefits in functional outcomes result only when inflammation is also decreased. Furthermore, long-term antiapoptotic therapy can result in nonapoptotic death with necrotic features, which will further increase inflammation and worsen outcome. Even though neuroprotective therapies are one of the targets for the promotion of functional recovery after SCI, targeting only post-SCI apoptosis is unlikely to be as successful as more integrated interventions that also target inflammation.

    AB - Mechanical trauma to the spinal cord triggers events resulting in the death of neurons and glia over several weeks following the initial injury. It has been suggested that the prevention of delayed apoptosis after spinal cord injury (SCI) is likely to have a beneficial effect by reducing the extent of neuronal and oligodendroglial death, which would translate into better functional outcomes. Drugs acting at different levels in the apoptotic cascade (i.e., caspase inhibitors and antiapoptotic Bcl-xL) have been shown to decrease apoptotic cell death, but benefits in functional outcomes result only when inflammation is also decreased. Furthermore, long-term antiapoptotic therapy can result in nonapoptotic death with necrotic features, which will further increase inflammation and worsen outcome. Even though neuroprotective therapies are one of the targets for the promotion of functional recovery after SCI, targeting only post-SCI apoptosis is unlikely to be as successful as more integrated interventions that also target inflammation.

    KW - Apoptosis

    KW - Bcl-2 family

    KW - Bcl-xL

    KW - Caspases

    KW - Functional recovery

    KW - Inflammation

    KW - Necrosis

    KW - Neuronal cell death

    UR - http://www.scopus.com/inward/record.url?scp=34447302064&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=34447302064&partnerID=8YFLogxK

    U2 - 10.2217/14796708.2.4.425

    DO - 10.2217/14796708.2.4.425

    M3 - Article

    AN - SCOPUS:34447302064

    VL - 2

    SP - 425

    EP - 434

    JO - Future Neurology

    JF - Future Neurology

    SN - 1479-6708

    IS - 4

    ER -